NCT00864201View on ClinicalTrials.gov

A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

PHASE3UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Hypertension, PulmonaryConnective Tissue Disease
Interventions
DRUG

bosentan

bosentan 62mg bid x 4 weeks, followed by bosentan 125mg bid x 20 weeks

Trial Locations (1)

L8L 5G4

Victoria Medical Center, Hamilton

Sponsors

Collaborators (1)

Actelion
All Listed Sponsors
collaborator

Actelion

INDUSTRY

lead

Hamilton Health Sciences Corporation

OTHER